fashion -WSS

fashion

author：fashion 2025-09-11 10:30:41 - browse：82

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Free Covid tests will again be offered to all U.S. households

knowledge

WSS

What to expect as Trump is arraigned on his Jan 6. indictment

Why the drug industry's warnings on the IRA's impact fall short

What the airline industry can learn from medicine

The high personal cost of affirmative action for Black doctors

Information blocking fines are now fair game in health care

NIH launches clinical trials and new research office for long Covid

leisure time

fashion

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Infectious disease expert Jeanne Marrazzo assumes Fauci role

As demand for Covid shots wanes, Moderna seeks its next success

Amazon expands telehealth clinic nationwide

Duchenne breakthrough therapy leaves behind pioneering families

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Drug repurposing or repositioning? The language matters

Eli Lilly CEO gives to Mike Pence presidential super PAC

Moonlake's readout produced a cash windfall. Risks remain

FDA weighs limits of animal data in assessing artificial wombs

focus

People with substance use disorder deserve online privacy

House panel takes first step toward fixing drug shortages

'A game

Why the quest to eradicate polio has stumbled

Akili changes sales model for its ADHD video game treatment

Grad students accuse University of California of wage theft

knowledge

hotspot

hotspot

entertainment